Meds to Beds: A Quality Improvement Approach to Optimizing the Discharge Medication Process for Pediatric Patients

Insights

Implementing an on-site pharmacy and medication to bedside (MTB) program significantly increased discharge antibiotic prescriptions to the pharmacy and bedside delivery for pediatric patients. This initiative improved medication access and adherence post-discharge.

Area of Science:

  • * Health Services Research
  • * Pediatric Pharmacy Practice
  • * Medication Management

Background:

  • * On-site pharmacies and medication to bedside (MTB) programs can enhance patient prescription access and education prior to discharge.
  • * These programs aim to improve medication adherence and prevent adverse events in pediatric acute care settings.

Purpose of the Study:

  • * To improve pediatric acute care discharge processes.
  • * To increase the proportion of oral antibiotics prescribed to the on-site pharmacy from 15% to 70%.
  • * To increase the proportion of discharge oral antibiotics delivered to the patient's bedside from 0% to 50%.

Main Methods:

  • * The Model for Improvement framework guided iterative interventions.
  • * Interventions included enhancing on-site pharmacy capabilities, establishing an MTB program, and implementing secure electronic health record (EHR) messaging.
  • * Process measures tracked on-site pharmacy prescription rates and bedside delivery; outcomes assessed family satisfaction and safety reports; discharge before noon (DBN) served as a balancing measure.

Main Results:

  • * On-site pharmacy prescriptions increased from 15% to 86% post-intervention.
  • * Bedside medication delivery rose from 0% to 58%.
  • * No significant changes were observed in family satisfaction or medication-related safety reports; DBN varied.

Conclusions:

  • * Clinician and pharmacy staff collaboration successfully increased on-site pharmacy utilization and bedside antibiotic delivery for pediatric discharges.
  • * Key successful interventions involved enhanced pharmacy services, an optimized MTB program, and EHR-based communication.
  • * The study highlights the effectiveness of integrated pharmacy services in improving medication delivery processes.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
23
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
36
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
27
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
23
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
32
Discharge Summary Forms01:31

Discharge Summary Forms

The discharge summary is crucial as it enables a smooth transition from a healthcare facility to a patient's home or another care setting. This critical document facilitates seamless continuity of care, ensuring patients receive the necessary support and attention.
Here's a detailed look at the key components and guidelines for preparing a discharge summary:
961